indazoles has been researched along with 3-methyladenine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Lin, H; Liu, H; Sun, Q; Yuan, G; Zhang, L; Zhou, Q | 1 |
| Bruserud, Ø; Hatfield, KJ; Nepstad, I; Reikvam, H | 1 |
2 other study(ies) available for indazoles and 3-methyladenine
| Article | Year |
|---|---|
Adenosine monophosphate-activated protein kinase/mammalian target of rapamycin-dependent autophagy protects human dental pulp cells against hypoxia.
Topics: Adenine; AMP-Activated Protein Kinases; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Autophagy-Related Protein 12; Autophagy-Related Protein 5; Beclin-1; Cell Culture Techniques; Cell Hypoxia; Cell Survival; Cells, Cultured; Dental Pulp; Genetic Vectors; Guanylate Cyclase; Humans; Hypoxia-Inducible Factor 1; Indazoles; Membrane Proteins; Microtubule-Associated Proteins; Plasmids; Proto-Oncogene Proteins; Small Ubiquitin-Related Modifier Proteins; TOR Serine-Threonine Kinases; Tumor Suppressor Proteins | 2013 |
Pharmacological targeting of the PI3K/mTOR pathway alters the release of angioregulatory mediators both from primary human acute myeloid leukemia cells and their neighboring stromal cells.
Topics: Adenine; Adult; Aged; Aged, 80 and over; Bone Marrow Cells; Cytogenetics; Cytokines; Female; Humans; Indazoles; Leukemia, Myeloid, Acute; Male; Middle Aged; Molecular Targeted Therapy; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; RNA, Messenger; Signal Transduction; Sirolimus; Stromal Cells; Sulfonamides; TOR Serine-Threonine Kinases; Young Adult | 2013 |